SuperworthLifeStance Health price to free cash flow LFST
Market value divided by free cash flow over the last twelve months, since 2024.
- Today, Oct 23, 2026
- 28.4×
- Peer median
- 18.7×
LifeStance Health's price to free cash flow is 28.4× as of Oct 23, 2026.
The median for 10 hospital and care facility stocks of a similar size is 18.7×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 28.4× | 20.1× | 31.5× |
| 2025 | 23.2× | 14.2× | 87.2× |
| 2024 | 81.7× | 77.9× | 82.1× |
Against its peers
Companies in Medical - Care Facilities nearest LifeStance Health's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| LFSTLifeStance Health | 28.4× |
| CONConcentra Group Holdings Parent | 18.7× |
| SHCSotera Health | 45.8× |
| OPCHOption Care Health | 15.4× |
| NHCNational Healthcare | 25.2× |
| CHEChemed | 20.7× |
| PACSPACS | 16.6× |
| AVAHAveanna Healthcare | 18.4× |
| PRVAPrivia Health | n/m |
| ENSGEnsign | 24.4× |
| MDPediatrix Medical | 10.4× |
| Peer median | 18.7× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on LifeStance Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.